Generics - Oncology, Bayer

Filter

Current filters:

OncologyBayer

Popular Filters

Indian patent appeal board upholds compulsory license on Bayer's Nexavar

05-03-2013

After much delay, the verdict into German pharmaceutical major Bayer's (BAYN: DE) appeal against the…

Asia-PacificBayerGenericsNatco PharmaNexavarOncologyPatentsPharmaceutical

India's IPAB rejects Bayer's "stay petition" regarding Nexavar

18-09-2012

Over the weekend, the Intellectual Property Appellate Board (IPAB) of Chennai, India, has dismissed the…

Asia-PacificBayerGenericsLegalNatco PharmaNexavarOncologyPatentsPharmaceutical

Bayer attempts to block generic Nexavar in India again slammed by MSF

04-09-2012

German drug major Bayer (BAYN: DE) yesterday headed to India's Intellectual Property Appellate Board…

Asia-PacificBayerGenericsLegalNexavarOncologyPatentsPharmaceutical

Indian hearings on Bayer Nexavar compulsory license delayed

22-08-2012

India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German…

Asia-PacificBayerGenericsLegalNatco PharmaNexavarOncologyPatentsPharmaceutical

Bayer challenges Indian ruling on Nexavar patent

08-05-2012

German drug major Bayer (BAYN: DE) has launched an appeal against the Indian Patent Office, which a couple…

Asia-PacificBayerGenericsLegalNexavarOncologyPatentsPharmaceutical

Cipla slashes price of generic cancer drug Nexavar in India by 76%; other cuts too

04-05-2012

Indian drugmaker Cipla (BSE: 500087) has slashed the prices of certain life-saving cancer drugs used…

Asia-PacificAstraZenecaBayerCiplaGenericsIressaMerck & CoNexavarOncologyPharmaceuticalPricingTemodar

India issues compulsory license for Bayer cancer drug Nexavar

13-03-2012

The Indian Patent Office has issued the first-ever compulsory licence in India to a generic drug manufacturer.…

Asia-PacificBayerGenericsNatco PharmaNexavarOncologyPatentsPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top